{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:43:58Z","timestamp":1772034238213,"version":"3.50.1"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Nasopharyngeal carcinoma (NPC) is a malignant tumor caused by an infection of the epithelial cells of the nasopharynx, which is highly metastatic and aggressive. Due to the deep anatomical site and atypical early symptoms, the majority of NPC patients are diagnosed at terminal stages. There is growing evidence that microRNAs offer options for early detection, accurate diagnosis, and prediction of malignancy treatment response. Therefore, the purpose of this article was to identify microRNAs that predict the prognosis of patients with NPC by integrating biological information analysis. In this study, we utilized the GSE36682 dataset rooted in the Gene Expression Omnibus (GEO) data bank, including 62 cases of NPC tissues and six cases of non-cancerous tissues. The miRNAs were subjected to weighted gene co-expression network analysis, and hub miRNAs were screened for differentially upregulated miRNAs from modules highly correlated with tumor progression. We took a lot of time to calculate the risk scores of miRNA markers for 62 NPC patients, and incidentally combined the clinical survival information of patients to finally identify the three key miRNAs, and then divided the patients into low- and high-risk groups. Kaplan-Meier curve analysis revealed that the overall survival of patients in the high-risk group was obviously shorter than that of the low-risk group. Subsequently, the target genes of the three miRNAs were predicted and analyzed for functional enrichment. In summary, a prognostic predictive risk model based on three miRNA profiles may increase prognostic predictive value and provide reference information for the precise treatment of nasopharyngeal carcinoma.<\/jats:p>","DOI":"10.3389\/fonc.2021.823603","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T10:33:36Z","timestamp":1643279616000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Identification of a 3-miRNA Signature Associated With the Prediction of Prognosis in Nasopharyngeal Carcinoma"],"prefix":"10.3389","volume":"11","author":[{"given":"Jinhui","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global Cancer Statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA: Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal Carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-3-030-22254-3_2","article-title":"Current Perspectives on Nasopharyngeal Carcinoma","author":"Lee","year":"2019","journal-title":"Hum Cell Transform"},{"key":"B4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.14740\/wjon980w","article-title":"Incidence and Mortality of Nasopharynx Cancer and Its Relationship With Human Development Index in the World in 2012","volume":"7","author":"Mahdavifar","year":"2016","journal-title":"World J Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2012.01.007","article-title":"Genetic Predisposition Factors and Nasopharyngeal Carcinoma Risk: A Review of Epidemiological Association Studies, 2000\u20132011: Rosetta Stone for NPC: Genetics, Viral Infection, and Other Environmental Factors","volume":"22","author":"Hildesheim","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.5732\/cjc.010.10377","article-title":"The Prevalence and Prevention of Nasopharyngeal Carcinoma in China","volume":"30","author":"Cao","year":"2011","journal-title":"Chin J Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"12189","DOI":"10.18632\/oncotarget.2608","article-title":"EBV-Driven LMP1 and IFN-\u03b3 Up-Regulate PD-L1 in Nasopharyngeal Carcinoma: Implications for Oncotargeted Therapy","volume":"5","author":"Fang","year":"2014","journal-title":"Oncotarget"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.2147\/OTT.S188148","article-title":"Management of Recurrent Nasopharyngeal Carcinoma: Current Perspectives","volume":"12","author":"Perri","year":"2019","journal-title":"OncoTargets Ther"},{"key":"B9","doi-asserted-by":"publisher","first-page":"101890","DOI":"10.1016\/j.ctrv.2019.101890","article-title":"Management of Locally Recurrent Nasopharyngeal Carcinoma","volume":"79","author":"Lee","year":"2019","journal-title":"Cancer Treat Rev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.60.9347","article-title":"Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective","volume":"33","author":"Lee","year":"2015","journal-title":"J Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.647809","article-title":"Advances in the Pathogenesis and Therapeutic Strategies for Nasopharyngeal Carcinoma","volume":"11","author":"Yang","year":"2021","journal-title":"Front Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.molonc.2012.09.006","article-title":"MicroRNA and Cancer","volume":"6","author":"Jansson","year":"2012","journal-title":"Mol Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-0334","article-title":"Epstein\u2013Barr Virus miRNA BART2-5p Promotes Metastasis of Nasopharyngeal Carcinoma by Suppressing Rnd3","volume":"80","author":"Jiang","year":"2020","journal-title":"Cancer Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3233\/CBM-181852","article-title":"Plasma microRNA Expression Signature Involving miR-548q, miR-630 and miR-940 as Biomarkers for Nasopharyngeal Carcinoma Detection","volume":"23","author":"Zhuo","year":"2018","journal-title":"Cancer Biomarkers"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.18632\/oncotarget.3005","article-title":"Identification of a microRNA Signature Associated With Risk of Distant Metastasis in Nasopharyngeal Carcinoma","volume":"6","author":"Bruce","year":"2015","journal-title":"Oncotarget"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70102-X","article-title":"Prognostic Value of a microRNA Signature in Nasopharyngeal Carcinoma: A microRNA Expression Analysis","volume":"13","author":"Liu","year":"2012","journal-title":"Lancet Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3892\/or.2019.7316","article-title":"The Four\u2212microRNA Signature Identified by Bioinformatics Analysis Predicts the Prognosis of Nasopharyngeal Carcinoma Patients","volume":"42","author":"Zhang","year":"2019","journal-title":"Oncol Rep"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-00394-2","article-title":"Advances in Targeted Therapy Mainly Based on Signal Pathways for Nasopharyngeal Carcinoma","volume":"5","author":"Kang","year":"2020","journal-title":"Signal Transduction Targeted Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2019.1642421","article-title":"Transferrin-Targeting Redox Hyperbranched Poly (Amido Amine)-Functionalized Graphene Oxide for Sensitized Chemotherapy Combined With Gene Therapy to Nasopharyngeal Carcinoma","volume":"26","author":"Liu","year":"2019","journal-title":"Drug Deliv."},{"key":"B20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/genes8010021","article-title":"Targeting microRNAs in Cancer Gene Therapy","volume":"8","author":"Ji","year":"2017","journal-title":"Genes"},{"key":"B21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/CEJ.0000000000000221","article-title":"BART miRNAs: An Unimaginable Force in the Development of Nasopharyngeal Carcinoma","volume":"26","author":"Wang","year":"2017","journal-title":"Eur J Cancer Prev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1146\/annurev-immunol-032414-112326","article-title":"The Immunology of Epstein-Barr Virus\u2013Induced Disease","volume":"33","author":"Taylor","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms131013737","article-title":"The Criteria to Confirm the Role of Epstein-Barr Virus in Nasopharyngeal Carcinoma Initiation","volume":"13","author":"Gu","year":"2012","journal-title":"Int J Mol Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1126\/science.1096781","article-title":"Identification of Virus-Encoded microRNAs","volume":"304","author":"Pfeffer","year":"2004","journal-title":"Science"},{"key":"B25","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/path.4025","article-title":"The Pathological Roles of BART miRNAs in Nasopharyngeal Carcinoma","volume":"227","author":"Lo","year":"2012","journal-title":"J Pathol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2011.12.001","article-title":"The Role of miRNAs and EBV BARTs in NPC","volume":"22","author":"Marquitz","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-013-4577-y","article-title":"Regulation Network and Expression Profiles of Epstein-Barr Virus-Encoded microRNAs and Their Potential Target Host Genes in Nasopharyngeal Carcinomas","volume":"57","author":"Zeng","year":"2014","journal-title":"Sci China Life Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5217039","article-title":"The Oncogenic Role of miR-BART19-3p in Epstein-Barr Virus-Associated Diseases","volume":"2020","author":"Zhang","year":"2020","journal-title":"BioMed Res Int"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2009.0112","article-title":"MicroRNA hsa-miR-135b Regulates Mineralization in Osteogenic Differentiation of Human Unrestricted Somatic Stem Cells","volume":"19","author":"Schaap-Oziemlak","year":"2010","journal-title":"Stem Cells Dev"},{"key":"B30","first-page":"7767","article-title":"miR-135b-5p Regulates Human Mesenchymal Stem Cell Osteogenic Differentiation by Facilitating the Hippo Signaling Pathway","volume":"10","author":"Si","year":"2017","journal-title":"Int J Clin Exp Pathol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.03.006","article-title":"MicroRNA-135b Promotes Cancer Progression by Acting as a Downstream Effector of Oncogenic Pathways in Colon Cancer","volume":"25","author":"Valeri","year":"2014","journal-title":"Cancer Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-018-4631-z","article-title":"Differential Expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c Suggests a Field Effect in Oral Cancer","volume":"18","author":"Lopes","year":"2018","journal-title":"BMC Cancer"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2013.02.046","article-title":"miR-135b Coordinates Progression of ErbB2-Driven Mammary Carcinomas Through Suppression of MID1 and MTCH2","volume":"182","author":"Arigoni","year":"2013","journal-title":"Am J Pathol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021505","article-title":"Identification of Novel Biomarkers and Small-Molecule Compounds for Nasopharyngeal Carcinoma With Metastasis","volume":"99","author":"Mi","year":"2020","journal-title":"Medi"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-3224","article-title":"miR-141 Is a Key Regulator of Renal Cell Carcinoma Proliferation and Metastasis by Controlling EphA2 Expression","volume":"20","author":"Chen","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-13-0296","article-title":"miRNA-141, Downregulated in Pancreatic Cancer, Inhibits Cell Proliferation and Invasion by Directly Targeting MAP4K4","volume":"12","author":"Zhao","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2012.433","article-title":"miR-141 Regulates KEAP1 and Modulates Cisplatin Sensitivity in Ovarian Cancer Cells","volume":"32","author":"Van Jaarsveld","year":"2013","journal-title":"Oncogene"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2512","article-title":"miR-141 and miR-200a Act on Ovarian Tumorigenesis by Controlling Oxidative Stress Response","volume":"17","author":"Mateescu","year":"2011","journal-title":"Nat Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.64","article-title":"miR-141 is Involved in BRD7-Mediated Cell Proliferation and Tumor Formation Through Suppression of the PTEN\/AKT Pathway in Nasopharyngeal Carcinoma","volume":"7","author":"Liu","year":"2016","journal-title":"Cell Death Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.211","article-title":"MiR-125b Regulates Proliferation and Apoptosis of Nasopharyngeal Carcinoma by Targeting A20\/NF-\u03bab Signaling Pathway","volume":"8","author":"Zheng","year":"2017","journal-title":"Cell Death Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41389-017-0005-7","article-title":"Cadherin 6 is Activated by Epstein\u2013Barr Virus LMP1 to Mediate EMT and Metastasis as an Interplay Node of Multiple Pathways in Nasopharyngeal Carcinoma","volume":"6","author":"Zuo","year":"2017","journal-title":"Oncogenesis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"95799","DOI":"10.18632\/oncotarget.21329","article-title":"Diagnosis, Prognosis and Bioinformatics Analysis of lncRNAs in Hepatocellular Carcinoma","volume":"8","author":"Dai","year":"2017","journal-title":"Oncotarget"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1809934115","article-title":"ZFAND5\/ZNF216 is an Activator of the 26S Proteasome That Stimulates Overall Protein Degradation","volume":"115","author":"Lee","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28838","article-title":"Matrine Promotes Apoptosis in SW480 Colorectal Cancer Cells via Elevating MIEF1-Related Mitochondrial Division in a Manner Dependent on LATS2-Hippo Pathway","volume":"234","author":"Zhang","year":"2019","journal-title":"J Cell Physiol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-0858-7","article-title":"The MRVI1-AS1\/ATF3 Signaling Loop Sensitizes Nasopharyngeal Cancer Cells to Paclitaxel by Regulating the Hippo\u2013TAZ Pathway","volume":"38","author":"Zhu","year":"2019","journal-title":"Oncogene"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.823603\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T10:33:39Z","timestamp":1643279619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.823603\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":45,"alternative-id":["10.3389\/fonc.2021.823603"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.823603","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]},"article-number":"823603"}}